Immunology On Target

News About Receptor Logic

July 18, 2008 :

Receptor Logic TETF Investment Briefing

July 18, 2008 :

$2M grant seen as good omen for local biotech company (Abilene Reporter News)

July 17, 2008 :

Abilene urged to support biotechnology center (Abilene Reporter News)

February 27, 2008 :

Receptor Logic Teams With Sanofi Pasteur To Develop T Cell Receptor Mimics (TCRm™) for Vaccine Research

February 11, 2008 :

Receptor Logic Quarterly Update-Winter 2008

June 5, 2007 :

Receptor Logic Chief Scientist to Speak At FOCIS Immunology Conference

September 15, 2006 :

Antibody Targeting to Class I MHC-peptide Epitope Promotes Tumor Cell Death

September 30, 2004 :

Receptor Logic receives $2 million advanced technology program award

March 26, 2004 :

Emergent Technologies, Inc. licenses drug discovery technology from Texas Tech University

 

Applications and Literature

HLA-omics and cancer biomarkers: emerging tools and technologies for the medical laboratory

Receptor Logic Teams With Sanofi Pasteur To Develop T Cell Receptor Mimics (TCRm™) for Vaccine Research

Receptor Logic Quarterly Update-Winter 2008

Antibody Targeting to Class I MHC-peptide Epitope Promotes Tumor Cell Death

Direct Epitope Validation Using Monoclonal TCR Mimic Antibodies

Levels of Specific Peptide-HLA Class I Complex Determines Tumor Cell Susceptibility to CTL Killing

An Emergent Company